Choroidal Melanoma
Showing 1 - 25 of 2,972
Primary Indeterminate Lesions or Choroidal Melanoma
Recruiting
- Choroidal Melanoma
- Indeterminate Lesions of Eye
-
Tucson, Arizona
- +14 more
Dec 7, 2022
AU-011 or Plaque Radiotherapy for Primary Indeterminate Lesions
Recruiting
- Choroidal Melanoma
- Indeterminate Lesions
- Standard of Care
- AU-011
-
Royal Oak, Michigan
- +6 more
Jun 16, 2022
Uveal Melanoma Trial in Ribeirão Preto (Melphalan Injection, Plaque brachytherapy)
Enrolling by invitation
- Uveal Melanoma
- Melphalan Injection
- Plaque brachytherapy
-
Ribeirão Preto, SP, BrazilHospital das Clinicas da Faculdade de Medicina de Ribeirao Preto
May 29, 2023
Choroidal Melanoma Trial in Aurora (1000CsK Silicon Oil Tamponade)
Completed
- Choroidal Melanoma
- 1000CsK Silicon Oil Tamponade
-
Aurora, ColoradoUniversity of Colorado Eye Center
Mar 4, 2022
Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma Trial in United States (Belzupacap Sarotalocan, Suprachoroidal
Recruiting
- Choroidal Melanoma
- +3 more
- Belzupacap Sarotalocan
- +5 more
-
Birmingham, Alabama
- +32 more
Aug 23, 2023
Melanoma Trial in Nice (Protontherapy)
Terminated
- Melanoma
- Protontherapy
-
Nice, FranceCentre Antoine Lacassagne
Dec 12, 2022
Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma Trial in United States (Light-activated AU-011, Laser Activation)
Completed
- Uveal Melanoma
- +2 more
- Light-activated AU-011
- Laser Activation
-
Tucson, Arizona
- +12 more
Jan 12, 2022
Cytogenetic Study of Ocular Melanoma
Completed
- Choroidal Melanoma
-
Los Angeles, CaliforniaJules Stein Eye Institute
Mar 25, 2021
Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Choroidal and Ciliary Body Melanoma AJCC V8 Trial
Recruiting
- Metastatic Malignant Neoplasm in the Liver
- +2 more
- Carmustine
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson Univeristy
Nov 16, 2022
Choroidal Melanoma Trial in Paris (Blood sampling)
Completed
- Choroidal Melanoma
- Blood sampling
-
Paris, FranceInstitut Curie
Aug 6, 2020
BAP1 Testing in Instance Choroidal Nevi or Uveal Melanoma
Active, not recruiting
- Choroidal Nevi, Uveal Melanoma
-
Houston, Texas
- +2 more
Mar 24, 2021
Clinical and Histopathologic Characteristics of BAP1 Mutations
Completed
- Malignant Pleural Mesothelioma (MPM)
- +5 more
- tumor specimens
-
Harrison, New York
- +1 more
Jun 30, 2020
Optical Coherence Tomography of Retinal Abnormalities Associated
Terminated
- Ocular Melanoma
-
Los Angeles, CaliforniaJules Stein Eye Institute
Aug 8, 2019
Genetic Mutations and of Circulating mRNAs in Uveal Melanoma
Recruiting
- Uveal Melanoma
- blood sample examination
-
Catania, Italy
- +2 more
Dec 20, 2021
Exudative Retinal Detachment and Uveal Melanoma Trial in Boston (Dexamethasone intravitreal implant)
Recruiting
- Exudative Retinal Detachment and Uveal Melanoma
- Dexamethasone intravitreal implant
-
Boston, Massachusettsi. Ocular Melanoma Center, Massachusetts Eye and Ear
Jul 23, 2021
Uveal Melanoma Trial in Worldwide
Recruiting
- Uveal Melanoma
-
Boston, Massachusetts
- +14 more
Jun 28, 2022
Blood Vessel Patterns in Small Choroidal Tumors
Active, not recruiting
- Small Posterior Choroidal Tumors
-
Portland, OregonOHSU Knight Cancer Institute
Sep 10, 2021
Vascular Response to Brachytherapy Using Functional OCT
Active, not recruiting
- Uveal Melanoma
-
Portland, OregonOHSU Knight Cancer Institute
Jan 7, 2022
Radiation Retinopathy, Visual Impairment Trial (Faricimab, fluocinolone acetonide)
Not yet recruiting
- Radiation Retinopathy
- Visual Impairment
- Faricimab
- fluocinolone acetonide
- (no location specified)
Apr 25, 2023
Radiation Retinopathy Trial in United States (0.5 mg ranibizumab, Targeted Retinal Photocoagulation (TRP))
Completed
- Radiation Retinopathy
- 0.5 mg ranibizumab
- Targeted Retinal Photocoagulation (TRP)
-
Dallas, Texas
- +3 more
Mar 24, 2021
Diabetes, Type 2, Diabetic Retinopathy Trial (RLRL device)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Diabetic Retinopathy
- RLRL device
- (no location specified)
Mar 19, 2023
Myopia, Myopia Progression, Juvenile Myopia Trial in Waterloo (Diffusion Optics Technology (DOT) Pattern Spectacle Lens, Control
Not yet recruiting
- Myopia
- +2 more
- Diffusion Optics Technology (DOT) Pattern Spectacle Lens
- Control Spectacle Lens
-
Waterloo, Ontario, CanadaCentre for Ocular Research and Education
Dec 5, 2022
Retinal and Choroidal Microvascular Parameters in
Completed
- COVID-19 Pandemic
-
Guangzhou, Guangdong, ChinaGuangzhou First People's Hospital
Jul 18, 2023